Skip to main content
Get Alerts

Connecticut

Public Health Trace has 20,137 recall records and 1,016 outbreak investigations on file connected to Connecticut, with 27,190 reported illnesses across those outbreak investigations, republished from official FDA, USDA, and CDC sources.

20,137
Recalls distributed here
1,016
Outbreaks affecting this state
27,190
Reported illnesses
Recalls and outbreaks by year

A bar chart of recall and outbreak counts affecting this state by year, built from the complete yearly totals for this state, not a bounded preview.

  • Recalls
  • Outbreaks
Download CSV
View full recalls and outbreaks by year (54 years)
Recalls and outbreaks by year
YearRecallsOutbreaks
197301
197400
197500
197602
197701
197801
197900
198002
198101
198200
198300
198400
198500
198601
198701
198800
198900
199000
199100
199200
199300
199401
199500
199600
199700
199807
199907
200008
2001016
200207
200309
2004011
2005015
2006015
2007012
2008013
2009019
2010075
2011096
201239884
20131,15056
201470656
20151,70771
20161,63359
20171,96352
20181,39264
20192,19179
20201,08935
202194724
20222,07233
20231,86882
20241,0390
20251,0300
20269520

CDC NORS is a historical archive currently available through 2023; later zeros do not mean no outbreaks occurred.

Recall records distributed in Connecticut

Newest reported records first. Each record's own status (active, terminated, or not reported) is shown on its card.

FDA Recall Ongoing2026 recordClass II

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

by Apotex Corp.

Reason
Failed dissolution specifications.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05

by Par Health USA, LLC

Reason
Crystallization
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

by TerSera Therapeutics LLC

Reason
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3.

by Amneal Pharmaceuticals, LLC

Reason
Defective Container; packets were found to be either empty or partially full.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

by Ajanta Pharma USA Inc

Reason
Failed Dissolution Specifications: below specification
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing2026 recordClass I

TODD'S SEEDS LLC

Product
Todd's Seeds Variety Pack of Sprouting Seeds - Broccoli, Alf…
Reason
Products contain alfalfa seed recalled by the supplier and may be contaminated with E. coli and/or Salmonella (downstream recall)
Published
October 7, 2026
Distribution
Nationwide

View recall →

Showing 6 of 20,137 recall records

See all recalls in Connecticut

Outbreak records affecting Connecticut

Newest reported records first. Each record's own status (active investigation, historical, or monitoring) is shown on its card.

Showing 6 of 1,016 outbreak records

See all outbreaks in Connecticut

Companies with recalls distributed in Connecticut

Via the real distribution-state record on each recall -- distinct from the free-text match used for the recall cards above.

Disease surveillance trends

No disease surveillance trend data has been published for this state.

Data availability

Disease surveillance trends are only shown where CDC's reporting areas have been matched to this state. A state showing no surveillance data here may still have real recalls and outbreaks above - the gap is in state-level linkage for weekly case reports specifically, not an indication that nothing was reported.

Freshness unavailable for one or more included sources

This page combines recall records from the FDA and USDA with outbreak investigations and disease surveillance data from the CDC. It is not a safety ranking or comparison between states -- a higher count here can reflect more thorough reporting as much as more actual events, and is not a statement that Connecticut is more or less safe than any other state. Read the full medical disclaimer.